DA-2811

DRUG4 trials

Sponsors

Dong-A ST Co., Ltd.

Conditions

Diabete MellitusDiabetes MellitusHealthy

Phase 1

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects

CompletedNCT04473417

Dong-A ST Co., Ltd.Healthy

Start: 2020-08-04End: 2020-10-12Updated: 2021-03-05

Pharmacokinetics and Safety/Tolerability Profiles of DA-2811 in Healthy Subjects (DA-2811)

CompletedNCT04938752

Dong-A ST Co., Ltd.Healthy

Start: 2021-07-08End: 2021-08-20Updated: 2022-06-06

Phase 2

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Not yet recruitingNCT07239440

Dong-A ST Co., Ltd.Diabete Mellitus

Start: 2025-11-30End: 2027-06-30Target: 288Updated: 2025-11-20

Phase 4

Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing Metformin Monotherapy in Patients with Type 2 Diabetes Who Have Inadequate Glycemic Control

CompletedNCT05743907

Dong-A ST Co., Ltd.Diabetes Mellitus

Start: 2023-04-25End: 2025-03-10Updated: 2025-03-14